Concomitant and sequential administration of nirmatrelvir‐ritonavir and azvudine in patients with COVID‐19 caused by the Omicron variant: Safety and efficacy

Concomitant and sequential administration of nirmatrelvir‐ritonavir and azvudine in patients with COVID‐19 caused by the Omicron variant: Safety and efficacy

Abstract Background This study assessed the safety and efficacy of nirmatrelvir‐ritonavir (Paxlovid®) and azvudine when administered sequentially or concomitantly in patients with coronavirus 2019 (COVID‐19) caused by the Omicron variant. Methods Ninety‐three patients confirmed to be infected with t...

Full description

Saved in:
Bibliographic Details
Main Authors: Guang‐Bin Chen, You‐Rou Zheng, Yun‐Ni Yu, Li‐Mian Liang, Chao Chen, Ying‐Xia Liu, Hong‐Zhou Lu
Format: Article
Language:English
Published: Wiley 2024-06-01
Series:iLabmed
Subjects:
adverse drug reactions
azvudine
efficacy
nirmatrelvir‐ritonavir
Omicron variant
safety
Online Access:https://doi.org/10.1002/ila2.40
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/ila2.40

Similar Items